![]() |
| Site Navigation | Chemotherapy - Vincristine |
|
|
|
| Vincristine (also called Oncovin or VCR) is
a chemotherapy agent used in the treatment of Non-Hodgkin's
lymphoma and Hodgkin's
Lymphoma / Disease. It is
more often than not given in conjunction with other chemotherapy agents in a multidrug
regimen. An antineoplastic, vincristine interferes with the growth of cancer cells - it
does this by inhibiting microtubule production on cells. It is in the vinca alkaloid
family of drugs which includes vinblastine, a very
different drug, sometimes used to treat Hodgkin's Disease. Both vinblastine and
vincristine are used in the Stanford V regimen whereas
vincristine alone is used in CHOP. Originally derived from the
Madagascar periwinkle plant Catharanthus roseus. Before
taking this medicine: Inform the doctor if you have had kidney, liver, or lung
disease. It should not be taken while pregnant and not while breast feeding without your
doctors' advise. Some of the Regimens using Vincristine:
Vincristine Reference Links:
Manufacturer
Disclaimer: This information is general in nature. Please consult with a doctor or the literature provided with the drugs if you need specific information on a drug. The author is not responsible for missing or inaccurate information and the reader assumes full responsibility for their actions. As always, please consult with medical personnel before undertaking any medical treatment. For more information on Hodgkin's Disease, please see the following pages: :
For more information on Non-Hodgkin's Lymphoma, please see the following pages: :
The Main Page - gateway to support and more This page is a work in progress - if you have more complete information, references, or other information please contact the author. The author is not in the medical field and does not warrant the correctness of the material on this page or the sites linked - please take online information and consult with your own medical team to make informed decisions. Copyright © 1998-2006 Lymphoma Information
Network - All Rights Reserved |
||